Early NF1 gene changes show up in just one kind of brain cell
Original title: Pervasive Somatic Mutations in NF1 Drive Cell Type and Spatially Specific Clonal Selection in Neurofibromatosis
How far along is this research?
This is a preprint. Other scientists have not checked it yet, so treat it as an early signal rather than an answer.
This was early lab work on brain tissue, not a test of a treatment.
The short version
In brain tissue from people with NF1, a second gene change built up in only one kind of brain cell.
What was studied. Researchers looked at more than 1.7 million single cells from people with neurofibromatosis type 1. They checked which cells carried a second change in the NF1 gene, and where in the brain those cells sat.
What they found. The second gene change was common. It built up in brain cells called oligodendrocyte: A helper cell in the brain and spinal cord. It wraps nerve fibers in a fatty coat called myelin, which helps nerve signals move. An oligodendroglioma starts in cells that look like these. See the glossary, and in the young cells they come from. It was very rare in nerve cells and other cell types. The changed young cells grew more in gray matter than in white matter. They also made more of a gene called CDKN2A, and brain cancers from the same people had lost that gene.
What this means, and what it doesn't
What it could mean: This gives a clue about where NF1 brain tumors may begin, and which cells to watch. It does not change any care a patient gets today.
What it doesn't mean: This is early lab work on brain tissue. No drug or treatment was tested here. It is not a cure and it is not a promise of one. It is a long way from everyday care. It also does not mean that a person with these cell changes will get a tumor.
Source: bioRxiv (preprint), September 30, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.